|
Market Closed -
OTC Markets
09:33:20 2026-08-26 EDT
|
5-day change | 1st Jan Change | ||
| 1.085 USD | -9.58% |
|
-.--% | +5.34% |
| 09-10 | UBS starts Bellway and Taylor Wimpey at 'sell' | AN |
| 08-27 | WINNERS & LOSERS: Tech stocks track Nvidia up, Halfords leads FTSE 250 | AN |
Company Valuation: Dr. Martens plc
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,520 | 1,360 | 844 | 502.5 | 603.6 | 641.3 | - | - |
| Change | - | -46.04% | -37.94% | -40.47% | 20.12% | 6.24% | - | - |
| Enterprise Value (EV) 1 | 2,686 | 1,648 | 1,202 | 748.3 | 816.8 | 837.9 | 806.2 | 776.5 |
| Change | - | -38.63% | -27.11% | -37.72% | 9.16% | 2.58% | -3.78% | -3.69% |
| P/E | 13.9x | 10.5x | 12.5x | 104x | 26x | 13.6x | 10.9x | 9.31x |
| PBR | 7.7x | 3.36x | 2.35x | 1.37x | 1.69x | 1.65x | 1.48x | 1.3x |
| PEG | - | -0.4x | -0.3x | -1.1x | 0x | 0x | 0.4x | 0.5x |
| Capitalization / Revenue | 2.77x | 1.36x | 0.96x | 0.64x | 0.79x | 0.82x | 0.78x | 0.74x |
| EV / Revenue | 2.96x | 1.65x | 1.37x | 0.95x | 1.07x | 1.07x | 0.98x | 0.9x |
| EV / EBITDA | 10.2x | 6.73x | 6.08x | 6.4x | 5.53x | 5.18x | 4.51x | 4x |
| EV / EBIT | 11.7x | 9.35x | 9.83x | 20.2x | 10.3x | 9.2x | 7.61x | 6.55x |
| EV / FCF | 20.3x | 63.6x | 8.61x | 4.21x | 6.24x | 18.2x | 13.6x | 11.9x |
| FCF Yield | 4.92% | 1.57% | 11.6% | 23.7% | 16% | 5.48% | 7.35% | 8.37% |
| Dividend per Share 2 | 0.055 | 0.0584 | 0.0255 | 0.0255 | 0.0255 | 0.025 | 0.0254 | 0.0254 |
| Rate of return | 2.18% | 4.3% | 2.91% | 4.89% | 4.09% | 3.73% | 3.79% | 3.79% |
| EPS 2 | 0.181 | 0.129 | 0.07 | 0.005 | 0.024 | 0.0494 | 0.0615 | 0.072 |
| Distribution rate | 30.4% | 45.3% | 36.4% | 510% | 106% | 50.6% | 41.2% | 35.3% |
| Net sales 1 | 908.3 | 1,000 | 877.1 | 787.6 | 764.9 | 783.6 | 821.8 | 863.2 |
| EBITDA 1 | 263 | 245 | 197.5 | 117 | 147.7 | 161.6 | 178.7 | 194.4 |
| EBIT 1 | 229.3 | 176.2 | 122.2 | 37 | 79.3 | 91.06 | 105.9 | 118.6 |
| Net income 1 | 181.2 | 128.9 | 69.2 | 4.5 | 23.8 | 48.53 | 60.18 | 70.35 |
| Net Debt 1 | 165.8 | 288.3 | 357.5 | 245.8 | 213.2 | 196.7 | 165 | 135.2 |
| Reference price 2 | 2.5200 | 1.3590 | 0.8775 | 0.5210 | 0.6240 | 0.6700 | 0.6700 | 0.6700 |
| Nbr of stocks (in thousands) | 1,000,111 | 1,000,770 | 961,879 | 964,499 | 967,344 | 957,113 | - | - |
| Announcement Date | 6/1/22 | 6/1/23 | 5/30/24 | 6/5/25 | 5/19/26 | - | - | - |
1GBP in Million2GBP
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 10.61x | 1.54x | 6.64x | -.--% | 10.86B | ||
| 9.42x | 1.66x | 6.8x | -.--% | 5.9B | ||
| 16.03x | 1.47x | 8.2x | 5.12% | 5.56B | ||
| 15.29x | 2.46x | 8.04x | -.--% | 5.54B | ||
| 12.79x | 0.3x | 4.07x | 5.91% | 2.56B | ||
| 6.28x | - | - | - | 2.29B | ||
| 11.9x | 0.98x | 8.86x | 2.08% | 1.59B | ||
| 11.23x | 1.65x | 7.45x | 4.19% | 1.48B | ||
| 13.27x | 0.83x | 6.42x | 5.34% | 1.16B | ||
| Average | 11.87x | 1.36x | 7.06x | 2.83% | 4.1B | |
| Weighted average by Cap. | 11.98x | 1.56x | 7.08x | 1.71% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DOCS Stock
- DOCMF Stock
- Valuation Dr. Martens plc
Select your edition
All financial news and data tailored to specific country editions
















